Aging and cancer vaccines

Claudia Gravekamp, Dinesh Chandra

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cancer vaccination is less effective at old than at young age, due to T cell unresponsiveness. This is caused by age-related changes of the immune system. Major immune defects at older age are lack of naïve T cells, impaired activation pathways of T cells and antigen-presenting cells (APC), and age-related changes in the tumor microenvironment (TME). Also innate immune responses are affected by aging, but this seems less abundant than adaptive immune responses. In this review we compared various cancer vaccine studies at young and old age, demonstrating the importance of both innate and adaptive immune responses for cancer immunotherapy. Moreover, we found suggestive evidence that innate immune responses could help improve adaptive immune responses through cancer vaccination in old age.

Original languageEnglish (US)
Pages (from-to)585-595
Number of pages11
JournalCritical Reviews in Oncogenesis
Volume18
Issue number6
DOIs
StatePublished - 2013

Fingerprint

Cancer Vaccines
Adaptive Immunity
Innate Immunity
T-Lymphocytes
Vaccination
Neoplasms
Tumor Microenvironment
Viral Tumor Antigens
Antigen-Presenting Cells
Immunotherapy
Immune System

Keywords

  • Adaptive immune responses
  • Aging
  • Cancer vaccination
  • Innate immune responses
  • Listeria monocytogenes
  • T cell unresponsiveness

ASJC Scopus subject areas

  • Cancer Research

Cite this

Aging and cancer vaccines. / Gravekamp, Claudia; Chandra, Dinesh.

In: Critical Reviews in Oncogenesis, Vol. 18, No. 6, 2013, p. 585-595.

Research output: Contribution to journalArticle

Gravekamp, Claudia ; Chandra, Dinesh. / Aging and cancer vaccines. In: Critical Reviews in Oncogenesis. 2013 ; Vol. 18, No. 6. pp. 585-595.
@article{6493402aaa4c4f57873b4220ef1dbdaf,
title = "Aging and cancer vaccines",
abstract = "Cancer vaccination is less effective at old than at young age, due to T cell unresponsiveness. This is caused by age-related changes of the immune system. Major immune defects at older age are lack of na{\"i}ve T cells, impaired activation pathways of T cells and antigen-presenting cells (APC), and age-related changes in the tumor microenvironment (TME). Also innate immune responses are affected by aging, but this seems less abundant than adaptive immune responses. In this review we compared various cancer vaccine studies at young and old age, demonstrating the importance of both innate and adaptive immune responses for cancer immunotherapy. Moreover, we found suggestive evidence that innate immune responses could help improve adaptive immune responses through cancer vaccination in old age.",
keywords = "Adaptive immune responses, Aging, Cancer vaccination, Innate immune responses, Listeria monocytogenes, T cell unresponsiveness",
author = "Claudia Gravekamp and Dinesh Chandra",
year = "2013",
doi = "10.1615/CritRevOncog.2013010588",
language = "English (US)",
volume = "18",
pages = "585--595",
journal = "Critical Reviews in Oncogenesis",
issn = "0893-9675",
publisher = "Begell House Inc.",
number = "6",

}

TY - JOUR

T1 - Aging and cancer vaccines

AU - Gravekamp, Claudia

AU - Chandra, Dinesh

PY - 2013

Y1 - 2013

N2 - Cancer vaccination is less effective at old than at young age, due to T cell unresponsiveness. This is caused by age-related changes of the immune system. Major immune defects at older age are lack of naïve T cells, impaired activation pathways of T cells and antigen-presenting cells (APC), and age-related changes in the tumor microenvironment (TME). Also innate immune responses are affected by aging, but this seems less abundant than adaptive immune responses. In this review we compared various cancer vaccine studies at young and old age, demonstrating the importance of both innate and adaptive immune responses for cancer immunotherapy. Moreover, we found suggestive evidence that innate immune responses could help improve adaptive immune responses through cancer vaccination in old age.

AB - Cancer vaccination is less effective at old than at young age, due to T cell unresponsiveness. This is caused by age-related changes of the immune system. Major immune defects at older age are lack of naïve T cells, impaired activation pathways of T cells and antigen-presenting cells (APC), and age-related changes in the tumor microenvironment (TME). Also innate immune responses are affected by aging, but this seems less abundant than adaptive immune responses. In this review we compared various cancer vaccine studies at young and old age, demonstrating the importance of both innate and adaptive immune responses for cancer immunotherapy. Moreover, we found suggestive evidence that innate immune responses could help improve adaptive immune responses through cancer vaccination in old age.

KW - Adaptive immune responses

KW - Aging

KW - Cancer vaccination

KW - Innate immune responses

KW - Listeria monocytogenes

KW - T cell unresponsiveness

UR - http://www.scopus.com/inward/record.url?scp=84893068429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893068429&partnerID=8YFLogxK

U2 - 10.1615/CritRevOncog.2013010588

DO - 10.1615/CritRevOncog.2013010588

M3 - Article

C2 - 24579737

AN - SCOPUS:84893068429

VL - 18

SP - 585

EP - 595

JO - Critical Reviews in Oncogenesis

JF - Critical Reviews in Oncogenesis

SN - 0893-9675

IS - 6

ER -